XXII
22nd Century Group Inc
Stock NYSE – Stock Market Prices, News & Analysis
22nd Century Group Inc is a biotechnology company focused on genetically modifying plants to control nicotine levels in tobacco and cannabinoids in cannabis.
22nd Century Group Inc
XXII
22nd Century Group Inc is a biotechnology company focused on genetically modifying plants to control nicotine levels in tobacco and cannabinoids in cannabis.
Price history of 22nd Century Group Inc
Price history of 22nd Century Group Inc
Performance & Momentum
Strategic Analysis
22nd Century Group Inc • 2026
22nd Century Group Inc positions itself as an innovative player in biotechnology by genetically modifying plants to adjust nicotine and cannabinoid levels, thereby targeting regulated and evolving markets. Its genetic expertise gives it a specific niche in the healthcare sector, with a model focused on scientific value creation and addressing public health issues related to tobacco and cannabis.
- Unique positioning in the targeted genetic modification of plants for therapeutic and recreational uses
- Advanced and patented scientific expertise in nicotine and cannabinoid levels
- Growth potential linked to regulatory changes in the tobacco and cannabis industries
- Extremely poor stock performance track record over recent years
- No current catalysts or positive short-term news flow
Momentum is very weak, reflecting clear investor skepticism about current financial and operational prospects. This prolonged downward trend calls for heightened caution, as the valuation reflects elevated risks and a need for a tangible rebound to reverse the trend.
Similar stocks to 22nd Century Group Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
